Vision Care Market Research Report - Global Forecast till 2025

Vision Care Market Research Report - Global Forecast till 2025

ID: MRFR/HC/6978-HCR | November, 2019 | Region: Global | 127 pages | Half-Cooked Research Reports

Market Forecast


Vision Care Market is expected to cross USD 70,818.48 Million by 2025 at a CAGR of 4.48%


Market Synopsis


Vision care is the heath setting that deals with the treatments, cosmetic modifications, and other procedures, products, and services related to the vision(eyes). The eye is a critical and important part of the body. It needs to be taken care on a regular basis.


Thus, it is among the other reasons why vision care is needed for healthy vision.


The refractive errors in the young population are expected to increase during the forecast period.


Market Influencer


Rising prevalence of diabetes as it is the leading cause of diabetic retinopathy.


Market Drivers



  • Growing global geriatric population.

  • Increasing prevalence of visual inaccuracies and eye disorders

  • Raising awareness of vision care products and services.

  • Increasing refractive error among the young population


Market Restraints



  • Unawareness about the vision care products and services.

  • Contact lens-related complications.


Segmentation


By Product Type


The global vision care market based on product type is broadly segmented into a contact lens, eyeglasses, intraocular lens (IOL), contact lens solutions, and others.



  • Contact Lens: This segment is further sub-segmented into the corrective lens, therapeutic lens, cosmetic, and lifestyle-oriented lens. A corrective lens is generally used as an option for glasses. It is used to correct the refractive error in the human vision. The therapeutic lens is also a bandage lens; these lenses are designed to treat a sick eye. It is combined medication to provide the desired effect.


The cosmetic and lifestyle-oriented lens is the contact lens that is used as an aid to enhance the beauty and appearance of the person. These type of contact lenses are available as per the customization of color and design patterns along with the power of the lenses




  • Eyeglasses: The eyeglasses are widely used for vision care around the globe. This segment the largest share in the global vision care market. This segment is further segmented into Bifocal, Single Vision, Progressive, Sunglasses.




  • Intraocular Lens (IOL): IOLs are the artificial lens that is implanted as a treatment for cataract. A cataract is responsible for 48% of world blindness. Thus, it is expected to a larger contribution to the global vision care market share. Based on the type of IOL market is segmented in premium, traditional/mono-focal, phakic. This type of product is implanted into the patient depending on the visual power of the eyes. In some cases, after the implant of the IOL the patients may also need eyeglasses. For instance, in a patient, mono-focal IOL is implanted for its far vision. In this case, the patient has to use eyeglasses for its near vision. In the market variety of IoL are available bases on is material, cost, focal power, etc.




  • Contact lens solutions: It is the solution that is used to keep the contact lens wet during the storage. It helps in cleaning the glass. It is a sterile and isotonic solution to the pH of the human eye. It among the largely consumed vision care product as it is initial for keeping the contact lens free from contamination, wet, and safe from damage.




  • Others




By Indication


The global vision care market based on indication is segmented into refractive error, glaucoma, diabetic retinopathy, amblyopia, dry eyes, and others.




  • Refractive error: Refractive error is a very commonly observed eye disorder. It is a condition of the eye wherein it cannot focus the images from the objects. Due to refractive errors, there is a blurred vision, which is sometimes so severe that it causes visual impairment. This segment is the largest share in the global vision care market.




  • Glaucoma: It is an indication of the eye in which the optic nerves are damaged due to the increased intraocular pressure. The condition gets worse with the progress of time; the patient needs continuous monitoring. It is treatment includes medication, surgery, and other related procedures.




  • Diabetic Retinopathy: It is a complication in the eye that is caused by diabetes. It is a result of damage to the blood vessels of the light-sensitive tissue retina. The diabetic retinopathy segment is the fastest-growing segment owing to the rising prevalence of diabetes as it is major cause of diabetic retinopathy. For instance, in India the prevalence of diabetes is rising at faster rate and is expected to reach an alarming mark of about 9 million by the year 2025, and by 2030 it is estimated to attain 80 million marks.




  • Amblyopia: Amblyopia is a disorder in which the eyes fail to achieve normal visual acuity, even with the use of refractory correction by prescription eyeglasses or contact lenses. It is also known as lazy eye. Amblyopia is mainly observed in infancy and early childhood.




  • Dry Eyes: It is a very commonly observed condition of the eyes in which tears are not able to provide adequate lubrication for the eyes. It is cases for dry eyes that are malfunctioning of the tear glands, dry air, less blinking of an eyelid, and other reasons.




  • Others




By Treatment


The global vision care market based on treatment is segmented into surgery, medication, and others.




  • Surgery: The surgical procedures are carried out as a part of treatment. The surgery segment is sub-segmented into cataract surgery, cornea transplant, vitrectomy. The cataract surgery estimated to have the largest share in the global vision care market.




  • Laser therapy: It is used mainly in post-cataract complications in which there is a cloudy portion of the implanted lens. The procedure is also known as yttrium-aluminum-garnet (YAG) laser capsulotomy. In this procedure, a small opening is made in the clouded capsule to provide a clear path for the light can pass. It is a non-invasive procedure, and it takes the least time compared to other procedures.




  • Medication: It includes medication used for treatments of eyes related indications, post-surgery care, and others. The medication segment is sub-segmented into acetazolamide, acetylcysteine, gentamicin, and others.




  • Others




By End-User


The global vision care market based on treatment is segmented into eye hospitals & clinics, ambulatory surgery center, optical stores, and others.




  • Eye Hospitals & Clinics: It is the healthcare setting that provides vision care products and services. This segment holds the largest market share owing to the rising number of eye care hospitals and clinics.




  • Ambulatory Surgery Center: Ambulatory Surgery Center is the healthcare setting that provides services related explicitly to surgical procedure and post-surgical care.




  • Optical Stores: Optical Stores are the fastest-growing segment owing to the easy accessibility to the vision care products and services and a larger number of stores, including offline and online stores.




  • Others




By Region




  • Americas: America is the fastest-growing region owing to technological advancements in vision care products and services.




  • Europe: In Europe, it is the fastest-growing market for the vision care business owing to the rising prevalence of vision impairment in respective regions.




  • Asia-Pacific: This is the fastest-growing market for vision care on account of the increasing geriatric population in China and India owing to the rising prevalence of cataract, refractive impairments




  • Middle East & Africa: This region has a low share is due to the limited technological development, restricting the growth of the vision care market.




Key Players



  • ESSILORLUXOTTICA (France)

  • Bausch Health [Canada] (Bausch & Lomb Incorporated)

  • The Cooper Companies, Inc [US] (Cooper Vision)

  • NOVARTIS AG (Switzerland)

  • Cadila Healthcare [India] (Zydus Pharmaceuticals, Inc.)

  • Johnson & Johnson Services, Inc. (US)

  • Rayner Surgical Group Limited [UK] (Rayner Intraocular Lenses Limited)

  • Menicon (Japan)

  • Carl-Zeiss-Stiftung [Germany] (Carl Zeiss)

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis


6. GLOBAL VISION CARE MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Contact Lens

6.2.1. Corrective Lens

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.2.2. Therapeutic Lens

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.2.3. Cosmetic and Lifestyle Oriented Lens

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.3. Eyeglasses

6.3.1. Bifocal

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.3.2. Single Vision

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.3.3. Progressive

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.3.4. Sunglasses

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.4. Intraocular Lens (IOL)

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.4.1. Premium

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.4.2. Traditional/Mono-focal

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.4.3. Phakic

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.5. Contact Lens Solutions

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.6. Others

7. GLOBAL VISION CARE MARKET, BY INDICATION

7.1. Overview

7.2. Refractive error

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.3. Cataract

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.4. Glaucoma

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.5. Diabetic retinopathy

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.6. Amblyopia

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.7. Dry Eyes

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.8. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8. GLOBAL VISION CARE MARKET, BY TREATMENT

8.1. Overview

8.2. Surgery

8.2.1. Cataract Surgery

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.2.2. Vision correction procedures

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.2.2.1. Lasik Surgery

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.2.2.2. Implantable Contact Lens (ICL) surgery

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.2.2.3. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.2.3. Cornea transplant

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.2.4. Vitrectomy

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.3. Laser therapy

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.4. Medication

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.4.1. Acetazolamide

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.4.2. Acetylcysteine

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.4.3. Gentamicin

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.4.4. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.5. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

9. GLOBAL VISION CARE MARKET, BY END USER

9.1. Overview

9.2. Eye Hospitals & Clinics

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

9.3. Ambulatory Surgery Center

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

9.4. Optical Stores

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

9.5. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025


9.6. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

10. GLOBAL VISION CARE MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa


11. COMPANY LANDSCAPE

11.1.1. Overview

11.1.2. Competitive Analysis

12. COMPANY PROFILES

12.1. EssilorLuxottica

12.1.1. Company Overview

12.1.2. Product Type Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Bausch Health (Bausch & Lomb Incorporated)

12.2.1. Company Overview

12.2.2. Product Type Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. The Cooper Companies, Inc (Cooper Vision)

12.3.1. Company Overview

12.3.2. Product Type Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Novartis AG

12.4.1. Company Overview

12.4.2. Product Type Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Cadila Healthcare (Zydus Pharmaceuticals, Inc.)

12.5.1. Company Overview

12.5.2. Product Type Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Johnson & Johnson Services, Inc.

12.6.1. Company Overview

12.6.2. Product Type Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Rayner Surgical Group Limited (Rayner Intraocular Lenses Limited)

12.7.1. Company Overview

12.7.2. Product Type Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Menicon

12.8.1. Company Overview

12.8.2. Product Type Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.9. Carl-Zeiss-Stiftung (Carl Zeiss)

12.9.1. Company Overview

12.9.2. Product Type Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.10. Others

13. KEY STRATEGIES APPENDIX

13.1. References

13.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL VISION CARE MARKET SYNOPSIS, 2019–2025

TABLE 2 GLOBAL VISION CARE MARKET ESTIMATES & FORECAST, 2019–2025 (USD MILLION)

TABLE 3 GLOBAL VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (USD MILLION)

TABLE 4 GLOBAL VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 5 GLOBAL VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 6 GLOBAL VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 7 GLOBAL VISION CARE MARKET, BY REGION, 2019–2025 (USD MILLION)

TABLE 8 NORTH AMERICA: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (USD MILLION)

TABLE 9 NORTH AMERICA: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 10 NORTH AMERICA: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 11 NORTH AMERICA: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 12 US: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (USD MILLION)

TABLE 13 US: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 14 US: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 15 US: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 16 CANADA: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (US MILLION)

TABLE 17 CANADA: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 18 CANADA: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 19 CANADA: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 20 LATIN AMERICA: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (US MILLION)

TABLE 21 LATIN AMERICA: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 22 LATIN AMERICA: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 23 LATIN AMERICA: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 24 EUROPE: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (US MILLION)

TABLE 25 EUROPE: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 26 EUROPE: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 27 EUROPE: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 28 WESTERN EUROPE: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (US MILLION)

TABLE 29 WESTERN EUROPE: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 30 WESTERN EUROPE: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 31 WESTERN EUROPE: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 32 EASTERN EUROPE: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (US MILLION)

TABLE 33 EASTERN EUROPE: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 34 EASTERN EUROPE: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION

TABLE 35 EASTERN EUROPE: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 36 ASIA-PACIFIC: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (US MILLION)

TABLE 37 ASIA-PACIFIC: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 38 ASIA-PACIFIC: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 39 ASIA-PACIFIC: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: VISION CARE MARKET, BY PRODUCT TYPE, 2019–2025 (US MILLION)

TABLE 41 MIDDLE EAST & AFRICA: VISION CARE MARKET, BY INDICATION, 2019–2025 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: VISION CARE MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: VISION CARE MARKET, BY END USER, 2019–2025 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VISION CARE MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VISION CARE MARKET

FIGURE 4 GLOBAL VISION CARE MARKET SHARE, BY PRODUCT TYPE, 2018 (%)

FIGURE 5 GLOBAL VISION CARE MARKET SHARE, BY INDICATION, 2018 (%)

FIGURE 6 GLOBAL VISION CARE MARKET SHARE, BY TREATMENT, 2018 (%)

FIGURE 7 GLOBAL VISION CARE MARKET SHARE, BY END USER, 2018 (%)

FIGURE 8 GLOBAL VISION CARE MARKET SHARE, BY REGION, 2018 (%)

FIGURE 7 AMERICAS: VISION CARE MARKET SHARE BY REGION, 2018 (%)

FIGURE 9 NORTH AMERICA: VISION CARE MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 10 EUROPE: VISION CARE MARKET SHARE, BY REGION, 2018 (%)

FIGURE 11 WESTERN EUROPE: VISION CARE MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 12 ASIA-PACIFIC: VISION CARE MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 13 MIDDLE EAST & AFRICA: VISION CARE MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 14 GLOBAL VISION CARE MARKET: COMPANY SHARE ANALYSIS, 2018 (%)

FIGURE 15 ESSILORLUXOTTICA.: KEY FINANCIALS

FIGURE 16 ESSILORLUXOTTICA.: SEGMENTAL REVENUE

FIGURE 17 ESSILORLUXOTTICA.: REGIONAL REVENUE

FIGURE 18 BAUSCH HEALTH (BAUSCH & LOMB INCORPORATED): KEY FINANCIALS

FIGURE 19 BAUSCH HEALTH (BAUSCH & LOMB INCORPORATED): SEGMENTAL REVENUE

FIGURE 20 BAUSCH HEALTH (BAUSCH & LOMB INCORPORATED): REGIONAL REVENUE

FIGURE 21 THE COOPER COMPANIES, INC (COOPERVISION): KEY FINANCIALS

FIGURE 22 THE COOPER COMPANIES, INC (COOPERVISION): SEGMENTAL REVENUE

FIGURE 23 THE COOPER COMPANIES, INC (CooperVision): REGIONAL REVENUE

FIGURE 24 NOVARTIS AG.: KEY FINANCIALS

FIGURE 25 NOVARTIS AG.: SEGMENTAL REVENUE

FIGURE 26 NOVARTIS AG.: REGIONAL REVENUE

FIGURE 27 CADILA HEALTHCARE (ZYDUS PHARMACEUTICALS, INC.): KEY FINANCIALS

FIGURE 28 CADILA HEALTHCARE (ZYDUS PHARMACEUTICALS, INC.): SEGMENTAL REVENUE

FIGURE 29 CADILA HEALTHCARE (ZYDUS PHARMACEUTICALS, INC.): REGIONAL REVENUE

FIGURE 30 JOHNSON & JOHNSON SERVICES, INC.: KEY FINANCIALS

FIGURE 31 JOHNSON & JOHNSON SERVICES, INC.: SEGMENTAL REVENUE

FIGURE 32 JOHNSON & JOHNSON SERVICES, INC.: REGIONAL REVENUE

FIGURE 33 RAYNER SURGICAL GROUP LIMITED (RAYNER INTRAOCULAR LENSES LIMITED): KEY FINANCIALS

FIGURE 34 RAYNER SURGICAL GROUP LIMITED (RAYNER INTRAOCULAR LENSES LIMITED): SEGMENTAL REVENUE

FIGURE 35 RAYNER SURGICAL GROUP LIMITED (RAYNER INTRAOCULAR LENSES LIMITED): REGIONAL REVENUE

FIGURE 36 MENICON: KEY FINANCIALS

FIGURE 37 MENICON: SEGMENTAL REVENUE

FIGURE 38 MENICON: REGIONAL REVENUE

FIGURE 39 CARL-ZEISS-STIFTUNG (CARL ZEISS): KEY FINANCIALS

FIGURE 40 CARL-ZEISS-STIFTUNG (CARL ZEISS): SEGMENTAL REVENUE

FIGURE 41 CARL-ZEISS-STIFTUNG (CARL ZEISS): REGIONAL REVENUE



This table of content is tentative and subject to change as the research progresses.

Please note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.